Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NELARABINE for T-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where NELARABINE was used for T-cell lymphoma.

Most Reported Side Effects for NELARABINE

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 67 9.1% 6 40
Drug ineffective 50 6.8% 14 10
Myelopathy 47 6.4% 3 8
Neurotoxicity 47 6.4% 10 14
Neuropathy peripheral 45 6.1% 5 18
Muscular weakness 42 5.7% 6 14
Sepsis 39 5.3% 17 15
Peripheral sensory neuropathy 38 5.2% 3 7
Neutropenia 37 5.0% 8 10
Off label use 37 5.0% 5 6
Respiratory failure 34 4.6% 25 13
Guillain-barre syndrome 32 4.4% 15 13
Polyneuropathy 29 4.0% 1 5
Malignant neoplasm progression 28 3.8% 17 6
Hypoaesthesia 27 3.7% 1 13

Other Indications for NELARABINE

T-cell type acute leukaemia (238) Acute lymphocytic leukaemia (185) Product used for unknown indication (83) Non-hodgkin's lymphoma (47) Precursor t-lymphoblastic lymphoma/leukaemia (47) Acute lymphocytic leukaemia recurrent (14) Precursor t-lymphoblastic lymphoma/leukaemia refractory (12) Chemotherapy (10) Adult t-cell lymphoma/leukaemia (8) Precursor t-lymphoblastic leukaemia acute (7)

Other Drugs Used for T-cell lymphoma

CYCLOPHOSPHAMIDE (473) DOXORUBICIN (440) VINCRISTINE (392) ETOPOSIDE (321) METHOTREXATE (239) PREDNISONE (215) DEXAMETHASONE (200) BRENTUXIMAB VEDOTIN (199) GEMCITABINE (142) PREDNISOLONE (139)

Related Pages

NELARABINE Full Profile All T-cell lymphoma Drugs NELARABINE Demographics NELARABINE Timeline